a Study of SHR1210 in Combination With Paclitaxel-albumin and Carboplatin in Extensive Stage Small Cell Lung Cancer
Clinical trial NCT04790539 · UNKNOWN
Trial details
- NCT number
- NCT04790539
- Sponsor
- Shanghai Pulmonary Hospital, Shanghai, China
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-01
- Primary completion
- 2022-05-01
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.